Influence of lycopene on cell viability, cell cycle, and apoptosis of human prostate cancer and benign hyperplastic cells

Nutrition and Cancer

Volumn 65, Issue 7, 2013, Pages 1076-1085

  Soares, Nathalia Da Costa Pereira ^a   Teodoro, Anderson Junger ^b   Oliveira, Felipe Leite ^c   Santos, Carlos Antonio Do Nascimento ^d   Takiya, Christina Maeda ^c   Junior, Oswaldo Saback ^c   Bianco, Mario ^c   Junior, Antonio Palumbo ^c   Nasciutti, Luiz Eurico ^c   Ferreira, Luciana Bueno ^e   Gimba, Etel Rodrigues Pereira ^e,f   Borojevic, Radovan ^g  

^a Instituto de Ciencias Biomedicas   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

^e INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^f FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^g Excellion Biomedical Services   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LYCOPENE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CAROTENOIDS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; G1 PHASE; G2 PHASE; GENE EXPRESSION; HUMANS; MALE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 84888325524     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.812225     Document Type: Article

References (37)

1. Syed DN, Khan N, Afaq F, and Mukhtar H: Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev 16, 2193-2204, 2007.
2. Brasil Minist́erio da Sáude, Secretaria de Assist̂encia ̀a Sáude: Estimativa de novos casos de ĉancer de pŕostata 2012. Instituto Nacional do Ĉancer, 2012. Retrieved from http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/prostata
3. Corr̂ea NAB, Costa GFM, Massambani EM, Matumoto FH, and Paula MMM: Diagńostico precoce de carcinoma de pŕostata: ant́?geno prost́atico espeć?fico (PSA), um marcador quase ideal. Rev Bras Anal Clin 35, 63-64, 2003.
4. Dini LI and KoffWJ: Perfil do ĉancer de pŕostata no hospital de cĺ?nicas de Porto Alegre. Rev Assoc Med Bras 52, 28-31, 2006.
5. SrougiMand Simon SD (Eds.): Ĉancer uroĺogico, 2nd ed. Ed. Platina, S̃ao Paulo, Brazil, 1996.
6. Upadhyaya KR, Radha KS, andMadhyastha HK: Cell cycle regulation and induction of apoptosis by beta-carotene in U937 and HL-60 leukemia cells. J Biochem Mol Biol 40, 1009-1015, 2007.
7. Rao AV and Rao LG: Carotenoids and human health. Pharmacol Res 55, 207-216, 2007.
8. Ren D, Peng G, Huang H, Wang H, and Zhang S: Effect of rhodoxanthin from Potamogetoncrispus L. on cell apoptosis in Hela cells. Toxicology In Vitro 20, 1411-1418, 2007.
9. Slattery ML, Benson J, Curtin K, Ma K, Schaeffer D, et al.: Carotenoids and colon cancer. Am J Clin Nutr 71, 575-582, 2000.
10. Paiva SAR and Russell RM: Beta-carotene and other carotenoids as antioxidants. J Am Coll Nutr 18, 426-433, 1999.
11. Palozza P, Serini S, Maggiano N, Angelini M, Boninsegna A, et al.: Induction of cell cycle arrest and apoptosis in human colon adenocarcinoma cell lines by beta-carotene through down-regulation of cyclin A and bcl-2 family proteins. Carcinogenesis 23, 11-18, 2002.
12. Rodriguez-Amaya DB. A Guide to Carotenoid Analysis in Foods. International Life Sciences Institute Press, Washington, DC, 2001.
13. Levy J and Sharoni Y: The Functions of Tomato Lycopene and Its Role in Human Health. J American Botanical Council 62, 49-56, 2004.
14. Clareto SS: Estudo da Concentraç ̃ao de Licopeno da Polpa de Goiaba Utilizando o Processo de Microfiltraç ̃ao. Brasil: Tese de Doutorado em Tecnologia de Alimentos UNICAMP, 2007.
15. LaVecchia C: Mediterranean epidemiological evidence on tomatoes and the prevention of digestive tract cancers. Proc Soc Exp Bio Med 218, 125-128, 1997.
16. Giovannucci E, Liu Y, Stampfer MJ, and Willett WC: A prospective study of tomato products, lycopene and prostate cancer risk. J Natl Cancer Inst 94, 391-398, 2002.
17. Kim L, Rao AV, and Rao LG: Effects of Lycopene on prostate LNCaP cancer cells in culture. J Medicinal Food 5,181-187, 2002.
18. Rao AV: Lycopene and human health: summary and future directions. In: Tomatoes, Lycopene and Human Health. Ardersier, Scotland: Caledonian Science Press, 2006, pp. 223-228.
19. Bowen P, Chen L, and Stacewicz-Sapuntzakis M: Tomato sauce supplementation and prostate cancer: Lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med 10, 886-893, 2002.
20. Shami NJIE and Moreira EAM: Licopeno como agente antioxidante. Revista de Nutriç ̃ao 17, 227-236, 2004.
21. Levy J, Bosin E, Feldman B, Giat Y, Miinster A, et al.: Lycopene is a more potent inhibitor of human cancer cell proliferation than either alphacarotene or beta-carotene. Nutrition and Cancer 24, 257-266, 1995.
22. Jiang Z,WuCL,Woda BA,DresserK,Xu J, et al.: P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol 26, 1169-1174, 2002.
23. Molinie V, Herv́e JM, Lebret T, Lugagne-Delpon PM, Saporta F, et al.: Value of the antibody cocktail anti p63 + anti p504s for the diagnosis of prostatic cancer. Ann Path 24, 6-16, 2004.
24. Iwasa Y, Mizokami A, Miwa S, Koshida K, and Namiki M: Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP. Int J Urol 14, 233-239, 2007.
25. Teodoro AJ, Perrone D, Martucci RB, and Borojevic R: Lycopene isomerisation and storage in an in vitro model of murine hepatic stellate cells. Eur J Nutr 48, 261-268, 2009.
26. Ellinger S, Ellinger J, and Stehle P: Tomatoes, tomato products and lycopene in the prevention and treatment of prostate cancer: do we have the evidence from intervention studies? Curr Opin Clin Nutr Metab Care 9, 722-727, 2006.
27. Liu X, Allen JD, Arnold JT, and Blackman MR: Lycopene inhibits IGF-1 signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-1 production in co-cultured reactive stromal cells. Carcinogenesis 29, 816-823, 2008.
28. Ambrosio DN, Clugston RD, and Blaner WS: Vitamin A metabolism: an update. Nutrients 3, 63-103, 2011.
29. Yang Z, Zhang Z, Penniston KL, Binkley N, and Tanumihardjo SA: Serum carotenoid concentrations in postmenopausalwomen from the United States with and without osteoporosis. Int J Vitam Nutr Res 78, 105-111, 2008.
30. Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, et al.: Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene 20, 3428-3436, 2001.
31. Ivanov NI, Cowell SP, Brown P, Rennie PS, Guns ES, et al.: Lycopene differentially induces quiescence and apoptosis in androgen-responsive and-independent prostate cancer cell lines. Clin Nutr 26, 252-263, 2007.
32. Coffey RN, Watson RW, Hegarty PK, Watson CL, Wolohan L, et al.: Priming prostate carcinoma cells for increased apoptosis is associated with upregulation of the caspases. Cancer 92, 2297-2308, 2001.
33. Peehl DM: Primary cell cultures as models of prostate cancer development. Endocrine-Related Cancer 12, 19-47, 2005.
34. Peehl DM: Are primary cultures realistic models of prostate cancer? J Cell Biochem 91, 185-195, 2004.
35. Barclay WW, Woodruff RD, Hall MC, and Cramer SD: A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology 146, 13-18, 2005.
36. Cunha GR, Hayward SW, Wang YZ, and Ricke WA: Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107, 1-10, 2003.
37. Kramer G, Erdal H, Mertens HJ, Nap M, Mauermann J, et al.: Differentiation between cell deathmodes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res 64, 1751-1756, 2004.